Innate biosignature of treatment failure in human cutaneous leishmaniasis
Innate biosignature of treatment failure in human cutaneous leishmaniasis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The quality and magnitude of the immune and inflammatory responses determine the clinical outcome of
Leishmania
infection, and contribute to the efficacy of antileishmanial treatments. However, the precise immune mechanisms involved in healing or in the chronic immunopathology of human cutaneous leishmaniasis (CL) are not well understood. Thr...
Alternative Titles
Full title
Innate biosignature of treatment failure in human cutaneous leishmaniasis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1aa15e5b783e485fa0b3676f79b4da90
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1aa15e5b783e485fa0b3676f79b4da90
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-025-58330-3
